Nykode Company
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Investors Number:
5
Industry:
Tumor-Specific Antigens
Total Funding:
36596103
Last Funding Type:
Venture Round
Last Funding Date:
2016-12-16
Headquarters:
Oslo, Oslo, Norway
Funding Status:
Venture
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Founded Date:
2007-01-01